| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 220 | 2.221 | 5.731 | 9.159 | 1.187 | 0 |
| Total Income - EUR | - | - | - | - | 220 | 2.221 | 5.731 | 9.159 | 1.187 | 0 |
| Total Expenses - EUR | - | - | - | - | 2 | 203 | 429 | 470 | 77 | 73 |
| Gross Profit/Loss - EUR | - | - | - | - | 218 | 2.018 | 5.302 | 8.689 | 1.110 | -73 |
| Net Profit/Loss - EUR | - | - | - | - | 211 | 1.954 | 5.133 | 8.457 | 948 | -73 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuramo Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 260 | 2.227 | 5.330 | 8.654 | 988 | 910 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 6.105 | 2 | 2 |
| Cash | - | - | - | - | 260 | 2.227 | 5.330 | 2.549 | 986 | 908 |
| Shareholders Funds | - | - | - | - | 254 | 2.203 | 5.182 | 8.506 | 1.003 | 924 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 7 | 24 | 148 | 148 | -14 | -14 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuramo Med S.r.l.